본문 바로가기
KERD
논문KCI 등재

Clinical Characteristics of Methicillin-resistant Staphylococcus aureus Infection for Chronic Periprosthetic Hip and Knee Infection

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

초록

Purpose: Deep infection after hip and knee arthroplasty is a serious complication and is difficult to treat due toits toxicity. The aims of our study were to find out the differences of methicillin-resistant Staphylococcus aureus(MRSA) and methicillin-sensitive Staphylococcus aureus (MSSA) infection after hip and knee arthroplastyfocusing on clinical course and laboratory findings. Materials and Methods: We retrospectively reviewed 61 staphylococcal infection cases after hip and kneearthroplasty (MSSA in 25 patients, MRSA in 36 patients). Vital signs, laboratory tests, microbiology and clinicalcourses were analyzed. The average follow-up period was 3.8 years (range, 2 to 10.1 years). Results: At initial visit, MRSA group showed significant higher erythrocyte sedimentation rate, C-reactive protein(CRP) and neutrophil percentage. The average duration for the normalization of CRP was longer in MRSA group(MRSA: 36.7±25.1 days, MSSA: 24.7±13.6 days; P=0.008). The mean interval between staging operation waslonger in MRSA group (MRSA: mean 8.7 weeks [range, 6.4 to 21.4 weeks], MSSA: mean 6.8 weeks [range, 6 to13.1 weeks]; P=0.012). MRSA group (13.9%) revealed higher recurrence rate than MSSA group (4%). Two patients(5.6%) from MRSA group expired by sepsis. One limb amputation (2.7%) was carried out in MRSA group. Conclusion: MRSA infection after arthroplasty showed more toxic serologic parameter and poorer prognosis. Aggressive treatment should be considered for MRSA infection following arthroplasty.

Abstract

Purpose: Deep infection after hip and knee arthroplasty is a serious complication and is difficult to treat due toits toxicity. The aims of our study were to find out the differences of methicillin-resistant Staphylococcus aureus(MRSA) and methicillin-sensitive Staphylococcus aureus (MSSA) infection after hip and knee arthroplastyfocusing on clinical course and laboratory findings. Materials and Methods: We retrospectively reviewed 61 staphylococcal infection cases after hip and kneearthroplasty (MSSA in 25 patients, MRSA in 36 patients). Vital signs, laboratory tests, microbiology and clinicalcourses were analyzed. The average follow-up period was 3.8 years (range, 2 to 10.1 years). Results: At initial visit, MRSA group showed significant higher erythrocyte sedimentation rate, C-reactive protein(CRP) and neutrophil percentage. The average duration for the normalization of CRP was longer in MRSA group(MRSA: 36.7±25.1 days, MSSA: 24.7±13.6 days; P=0.008). The mean interval between staging operation waslonger in MRSA group (MRSA: mean 8.7 weeks [range, 6.4 to 21.4 weeks], MSSA: mean 6.8 weeks [range, 6 to13.1 weeks]; P=0.012). MRSA group (13.9%) revealed higher recurrence rate than MSSA group (4%). Two patients(5.6%) from MRSA group expired by sepsis. One limb amputation (2.7%) was carried out in MRSA group. Conclusion: MRSA infection after arthroplasty showed more toxic serologic parameter and poorer prognosis. Aggressive treatment should be considered for MRSA infection following arthroplasty.

참고문헌 (37)

  1. Blom AW, "Infection after total knee arthroplasty", J Bone Joint Surg Br, 86, pp.688~691 (2004)
  2. Kurtz SM, "Infection burden for hip and knee arthroplasty in the United States", J Arthroplasty, 23, pp.984~991 (2008)
  3. Peersman G, "Infection in total knee replacement: a retrospective review of 6489 total knee replacements", Clin Orthop Relat Res, 392, pp.15~23 (2001)
  4. Fehring TK, "Early failures in total knee arthroplasty", Clin Orthop Relat Res, 392, pp.315~318 (2001)
  5. Bjerke-Kroll BT, "Periprosthetic joint infections treated with two-stage revision over 14 years: an evolving microbiology profile", J Arthroplasty, 29, pp.877~882 (2014)
  6. Ridgeway S, "Infection of the surgical site after arthroplasty of the hip", J Bone Joint Surg Br, 87, pp.844~850 (2005)
  7. Cosgrove SE, "Comparison of mortality associated with methicillin-resistant and methicillinsusceptible Staphylococcus aureus bacteremia: a metaanalysis", Clin Infect Dis, 36, pp.53~59 (2003)
  8. Goyal N, "Methicillinresistant Staphylococcus aureus (MRSA): colonisation and pre-operative screening", Bone Joint J, 95-B, pp.4~9 (2013)
  9. Hawkshead JJ 3rd, "Comparative severity of pediatric osteomyelitis attributable to methicillin-resistant versus methicillin-sensitive Staphylococcus aureus", J Pediatr Orthop, 29, pp.85~90 (2009)
  10. Ju KL, "Differentiating between methicillin-resistant and methicillin-sensitive Staphylococcus aureus osteomyelitis in children: an evidence-based clinical prediction algorithm", J Bone Joint Surg Am, 93, pp.1693~1701 (2011)
  11. Saavedra-Lozano J, "Changing trends in acute osteomyelitis in children: impact of methicillin-resistant Staphylococcus aureus infections", J Pediatr Orthop, 28, pp.569~575 (2008)
  12. Salgado CD, "Higher risk of failure of methicillin-resistant Staphylococcus aureus prosthetic joint infections", Clin Orthop Relat Res, 461, pp.48~53 (2007)
  13. Parvizi J, "Periprosthetic joint infection: the economic impact of methicillin-resistant infections", J Arthroplasty, 25(6), pp.103~107 (2010)
  14. Tsukayama DT, "Infection after total hip arthroplasty. A study of the treatment of one hundred and six infections", J Bone Joint Surg Am, 78, pp.512~523 (1996)
  15. Workgroup Convened by the Musculoskeletal Infection Society, "New definition for periprosthetic joint infection", J Arthroplasty, 26, pp.1136~1138 (2011)
  16. Estes CS, "A twostage retention d?bridement protocol for acute periprosthetic joint infections", Clin Orthop Relat Res, 468, pp.2029~2038 (2010)
  17. Van Kleunen JP, "Irrigation and de´bridement and prosthesis retention for treating acute periprosthetic infections", Clin Orthop Relat Res, 468, pp.2024~2028 (2010)
  18. Koo KH, "Impregnation of vancomycin, gentamicin, and cefotaxime in a cement spacer for two-stage cementless reconstruction in infected total hip arthroplasty", J Arthroplasty, 16, pp.882~892 (2001)
  19. Meehan J, "Prophylactic antibiotics in hip and knee arthroplasty", J Bone Joint Surg Am, 91, pp.2480~2490 (2009)
  20. Della Valle CJ, "Analysis of frozen sections of intraoperative specimens obtained at the time of reoperation after hip or knee resection arthroplasty for the treatment of infection", J Bone Joint Surg Am, 81, pp.684~689 (1999)
  21. Pepe MS, "The statistical evaluation of medical tests for classification and prediction" (2004), Oxford University Press
  22. Bocchini CE, "Panton-Valentine leukocidin genes are associated with enhanced inflammatory response and local disease in acute hematogenous Staphylococcus aureus osteomyelitis in children", Pediatrics, 117, pp.433~440 (2006)
  23. Lo WT, "Panton-Valentine leukocidin is associated with exacerbated skin manifestations and inflammatory response in children with community-associated staphylococcal scarlet fever", Clin Infect Dis, 49, pp.e69~e75 (2009)
  24. Jung WJ, "Prediction of methicillin-resistant Staphylococcus aureus in patients with non-nosocomial pneumonia", BMC Infect Dis, 13, pp.370~ (2013)
  25. Berbari E, "Inflammatory blood laboratory levels as markers of prosthetic joint infection: a systematic review and meta-analysis", J Bone Joint Surg Am, 92, pp.2102~2109 (2010)
  26. Spangehl MJ, "Prospective analysis of preoperative and intraoperative investigations for the diagnosis of infection at the sites of two hundred and two revision total hip arthroplasties", J Bone Joint Surg Am, 81, pp.672~683 (1999)
  27. Insall JN, "Two-stage reimplantation for the salvage of infected total knee arthroplasty", J Bone Joint Surg Am, 65, pp.1087~1098 (1983)
  28. Petty W, "Infection after total knee arthroplasty", Orthop Clin North Am, 6, pp.1005~1014 (1975)
  29. Whittaker JP, "Is prolonged systemic antibiotic treatment essential in two-stage revision hip replacement for chronic Gram-positive infection?", J Bone Joint Surg Br, 91, pp.44~51 (2009)
  30. Aggarwal VK, "Periprosthetic joint infection: Current concept", Indian J Orthop, 47, pp.10~17 (2013)
  31. Dube´e V, "Continuous highdose vancomycin combination therapy for methicillinresistant staphylococcal prosthetic hip infection: a prospective cohort study", Clin Microbiol Infect, 19, pp.E98~E105 (2013)
  32. Liu C, "Targeted use of vancomycin as perioperative prophylaxis reduces periprosthetic joint infection in revision TKA", Clin Orthop Relat Res, 472, pp.227~231 (2014)
  33. Nickinson RS, "The microbiology of the infected knee arthroplasty", Int Orthop, 34, pp.505~510 (2010)
  34. Kuzyk PR, "Two-stage revision arthroplasty for management of chronic periprosthetic hip and knee infection:techniques, controversies, and outcomes", J Am Acad Orthop Surg, 22, pp.153~164 (2014)
  35. Hoad-Reddick DA, "Is there a role for extended antibiotic therapy in a two-stage revision of the infected knee arthroplasty?", J Bone Joint Surg Br, 87, pp.171~174 (2005)
  36. Deirmengian C, "Synovial fluid biomarkers for periprosthetic infection", Clin Orthop Relat Res, 468, pp.2017~2023 (2010)
  37. Jacovides CL, "Molecular markers for diagnosis of periprosthetic joint infection", J Arthroplasty, 26(6), pp.99~103 (2011)

관련 논문AI추천

이 간행물의 다른 논문 (11건)